Found: 45
Select item for more details and to access through your institution.
Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.
- Published in:
- EJNMMI Research, 2015, v. 5, n. 1, p. 1, doi. 10.1186/s13550-015-0126-y
- By:
- Publication type:
- Article
Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks.
- Published in:
- Frontiers in Neuroscience, 2017, v. 11, p. 1, doi. 10.3389/fnins.2017.00167
- By:
- Publication type:
- Article
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Reduced Myelotoxicity with Sustained Tumor Concentration of Radioimmunoconjugates in Rats after Extracorporeal Depletion.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 2, p. 269
- By:
- Publication type:
- Article
An Alternative Method to Normalize Clinical FDG Studies.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 3, p. 552
- By:
- Publication type:
- Article
<sup>18</sup>F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2017, v. 9, n. 9, p. 1212, doi. 10.15252/emmm.201707809
- By:
- Publication type:
- Article
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
- Published in:
- 2018
- By:
- Publication type:
- journal article
[sup 131]I-labelled Anti-CD22 MAb (LL2) in Patients with B-Cell Lymphomas Failing Chemotherapy.
- Published in:
- Acta Oncologica, 2002, v. 41, n. 3, p. 297, doi. 10.1080/02841860260088854
- By:
- Publication type:
- Article
Early Prediction of Treatment Outcome in Head and Neck Cancer with 2-<sup>18</sup>FDG PET.
- Published in:
- Acta Oncologica, 1997, v. 36, n. 7, p. 741, doi. 10.3109/02841869709001348
- By:
- Publication type:
- Article
A Pet System Based on 2-<sup>18</sup>Fdg Production with a Low Energy Electrostatic Proton Accelerator and a Dual Headed Pet Scanner.
- Published in:
- Acta Oncologica, 1992, v. 31, n. 7, p. 771, doi. 10.3109/02841869209083869
- By:
- Publication type:
- Article
FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma.
- Published in:
- Head & Neck, 2002, v. 24, n. 2, p. 127, doi. 10.1002/hed.10037
- By:
- Publication type:
- Article
Optimized regional analysis to detect longitudinal <sup>18</sup>F‐RO‐948 tau PET change in early AD: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045765
- By:
- Publication type:
- Article
O5‐01‐01: HEAD‐TO‐HEAD IN VIVO COMPARISON OF TAU POSITRON EMISSION TOMOGRAPHY LIGANDS <sup>18</sup>F‐FLORTAUCIPIR AND <sup>18</sup>F‐RO948.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1610, doi. 10.1016/j.jalz.2019.06.4834
- By:
- Publication type:
- Article
O3‐04‐04: <sup>18</sup>F‐FLORTAUCIPIR (AV‐1451) RETENTION IN PARKINSON'S DISEASE AND DEMENTIA WITH LEWY BODIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1020, doi. 10.1016/j.jalz.2018.06.2791
- By:
- Publication type:
- Article
O3‐04‐01: ASSOCIATIONS BETWEEN TAU, Aβ AND CORTICAL THICKNESS WITH COGNITION IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1018, doi. 10.1016/j.jalz.2018.06.2788
- By:
- Publication type:
- Article
P1‐430: EFFECTS OF APOE ε4 ON TAU, AMYLOID, ATROPHY AND COGNITION IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P473, doi. 10.1016/j.jalz.2018.06.439
- By:
- Publication type:
- Article
IC‐P‐218: <sup>18</sup>F‐FLORTAUCIPIR (AV‐1451) RETENTION IN PARKINSON'S DISEASE AND DEMENTIA WITH LEWY BODIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P178, doi. 10.1016/j.jalz.2018.06.2285
- By:
- Publication type:
- Article
REGIONAL DIFFERENCES IN THE TRANSIENT EQUILIBRIUM OF [18F]AV-1451 AND THEIR IMPACT ON TISSUE UPTAKE RATIOS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1486, doi. 10.1016/j.jalz.2017.07.567
- By:
- Publication type:
- Article
[18]F-AV-1451 PET IN CLINICALLY DIAGNOSED CORTICOBASAL DEGENERATION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P146, doi. 10.1016/j.jalz.2017.06.2574
- By:
- Publication type:
- Article
A prospective observational study to evaluate the effects of long-acting somatostatin analogs on <sup>68</sup>Ga-DOTATATE uptake in patients with neuroendocrine tumors.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.226332
- By:
- Publication type:
- Article
The Intratumoral Distribution of Radiolabeled <sup>177</sup>Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic Rat Colon Carcinoma Model.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 8, p. 1404, doi. 10.2967/jnumed.112.117028
- By:
- Publication type:
- Article
FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre.
- Published in:
- Acta Oncologica, 2006, v. 45, n. 6, p. 743, doi. 10.1080/02841860600644724
- By:
- Publication type:
- Article
Regional times to equilibria and their impact on semi-quantification of [ 18 F]AV-1451 uptake.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2019, v. 39, n. 11, p. 2223, doi. 10.1177/0271678X18791430
- By:
- Publication type:
- Article
Radiosynthesis and preclinical evaluation of [<sup>11</sup>C]Cimbi‐701 – Towards the imaging of cerebral 5‐HT<sub>7</sub> receptors.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2020, v. 63, n. 2, p. 46, doi. 10.1002/jlcr.3808
- By:
- Publication type:
- Article
Combined <sup>18</sup>F-fluorocholine and <sup>18</sup>F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
- Published in:
- BJU International, 2012, v. 110, n. 10, p. 1501, doi. 10.1111/j.1464-410X.2012.11123.x
- By:
- Publication type:
- Article
177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.
- Published in:
- 2010
- By:
- Publication type:
- journal article
<sup>177</sup>Lu-[DOTA0,Tyr3] Octreotate Therapy in Patients With Disseminated Neuroendocrine Tumors: Analysis of Dosimetry With Impact on Future Therapeutic Strategy.
- Published in:
- Cancer (0008543X), 2010, v. 116, p. 1084
- By:
- Publication type:
- Article
Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 7, p. 749, doi. 10.1001/jamaneurol.2023.1323
- By:
- Publication type:
- Article
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 2, p. 149, doi. 10.1001/jamaneurol.2021.4654
- By:
- Publication type:
- Article
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 8, p. 955, doi. 10.1001/jamaneurol.2020.0989
- By:
- Publication type:
- Article
Fragment-based labeling using condensation reactions of six potential 5-HT<sub>7</sub>R PET tracers.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2020, v. 326, n. 3, p. 1749, doi. 10.1007/s10967-020-07475-0
- By:
- Publication type:
- Article
Radiolabeling and in vivo evaluation of [<sup>11</sup>C]AGH-44: a potential lead structure to develop a positron emission tomography radioligand for the 5-HT<sub>7</sub> receptor.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2019, v. 322, n. 2, p. 847, doi. 10.1007/s10967-019-06687-3
- By:
- Publication type:
- Article
[<sup>18</sup>F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 5, p. 1371, doi. 10.1007/s00259-022-06065-4
- By:
- Publication type:
- Article
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 2, p. 342, doi. 10.1007/s00259-019-04496-0
- By:
- Publication type:
- Article
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
FDG-PET in cervical cancer: staging, re-staging and follow-up.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Comparison of cisplatin sensitivity and the I 8F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2009, v. 28, p. 1, doi. 10.1186/1756-9966-28-17
- By:
- Publication type:
- Article
Relationships between uptake of [<sup>68</sup>Ga]Ga-DOTA-TATE and absorbed dose in [<sup>177</sup>Lu]Lu-DOTA-TATE therapy.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00947-2
- By:
- Publication type:
- Article
Fully Automated GMP-Compliant Synthesis of [ 18 F]FE-PE2I.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 7, p. 601, doi. 10.3390/ph14070601
- By:
- Publication type:
- Article
Application of extracorporeal immunoadsorption to reduce circulating blood radioactivity after intraperitoneal administration of indium-111-HMFG1-biotin.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. S4, p. 1287, doi. 10.1002/cncr.10298
- By:
- Publication type:
- Article
Update on [18F]ACI‐12589: a novel and promising PET tracer for a‐synuclein.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.073125
- By:
- Publication type:
- Article
A prospective study evaluating the clinical utility of tau‐PET in the diagnostic work‐up of patients with cognitive symptoms.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075803
- By:
- Publication type:
- Article
Initial clinical scans using [<sup>18</sup>F]ACI‐12589, a novel α‐synuclein PET‐tracer.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065394
- By:
- Publication type:
- Article
Biomarker driven enrichment strategies for tau pathology in AD clinical trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055656
- By:
- Publication type:
- Article
Impact of reduced injected dose on the quantification of [<sup>18</sup>F]RO948 and [<sup>18</sup>F]Flortaucipir PET for in vivo tau pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055951
- By:
- Publication type:
- Article